NCT05839535

Brief Summary

This study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management approaches.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P75+ for phase_2 knee-osteoarthritis

Timeline
29mo left

Started Mar 2024

Longer than P75 for phase_2 knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Mar 2024Aug 2028

First Submitted

Initial submission to the registry

April 19, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

March 5, 2024

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

4.1 years

First QC Date

April 19, 2023

Last Update Submit

May 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • M1 resting state functional connectivity

    Changes in brain resting-state connectivity between the primary motor cortex (M1) and other brain regions pre- and post-treatments, analyzed using the CONN Toolbox (https://web.conn-toolbox.org/)

    Baseline, post-treatment (12 weeks)

Secondary Outcomes (9)

  • Change on Cerebral blood flow

    Baseline, post-treatment (12 weeks)

  • Change on M1 corticospinal excitability and cortico-cortical excitability

    Baseline, post-treatment (12 weeks)

  • Change on brain gray matter volume

    Baseline, post-treatment (12 weeks)

  • Change on Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Baseline, post-treatment (12 weeks), follow-up (24 weeks)

  • Change on Patient-Reported Outcomes Measurement Information System (PROMIS)-29

    Baseline, post-treatment (12 weeks), follow-up (24 weeks)

  • +4 more secondary outcomes

Study Arms (4)

BDJ + real tDCS

ACTIVE COMPARATOR
Behavioral: BDJDevice: tDCS

Exercise + real tDCS

ACTIVE COMPARATOR
Device: tDCSOther: exercise

BDJ + sham tDCS

ACTIVE COMPARATOR
Behavioral: BDJDevice: sham tDCS

Exercise + sham tDCS

ACTIVE COMPARATOR
Device: sham tDCSOther: exercise

Interventions

BDJBEHAVIORAL

BDJ is a mind-body intervention

BDJ + real tDCSBDJ + sham tDCS
tDCSDEVICE

tDCS is a brain stimulation method.

BDJ + real tDCSExercise + real tDCS
sham tDCSDEVICE

sham tDCS

BDJ + sham tDCSExercise + sham tDCS

exercise including stretching and other activities.

Exercise + real tDCSExercise + sham tDCS

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteers 45-75 years of age
  • Meet the Classification Criteria of the American College of Rheumatology for osteoarthritis of the right and/or left knee for at least the past 3 months;
  • Physically able to participate in the BDJ and stretching control education programs
  • Willing to complete the 12-week study
  • Can participate in MRI scan
  • Ability to read and understand English; English can be a second language provided that the patient feels he or she can understand all the questions used in the assessment measures

You may not qualify if:

  • Has performed BDJ, Tai Chi, Yoga, other mind-body intervention, physical therapy, or routine exercise (running, cycling, etc.) regularly in the past year
  • Serious medical conditions limiting ability of patient to participate in the study, such as symptomatic cardiovascular disease, symptomatic pulmonary disease requiring supplemental oxygen, uncontrolled metabolic diseases, severe renal and liver disease
  • Has had intra-articular steroid injections or reconstructive surgery in the prior 3 months on the affected knee; any intra-articular hyaluronic acid injections in the previous 6 months
  • Patient Mini-Mental Status Examination score below 24 \[293\]
  • Unable to walk without a cane or other assistive device
  • The intent to undergo surgery during the time of involvement in the study
  • Plan to permanently relocate from the region during the trial period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Charlestown, Massachusetts, 02129, United States

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Transcranial Direct Current StimulationExercise

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Clinical mechanism study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 19, 2023

First Posted

May 3, 2023

Study Start

March 5, 2024

Primary Completion (Estimated)

March 30, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

May 7, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations